by Thomas R. Collins – Using everolimus for immunosuppression in heart transplant recipients, along with a reduced amount of cyclosporine, produces results comparable to mycophenolate mofetil,
by Thomas R. Collins – TOL101, a new murine monoclonal antibody that targets the alpha-beta T-cell receptor, showed a good safety profile despite a problem with hives that… read more.
by Thomas R. Collins – Using a high dose of insulin is associated with a high risk of pancreas loss after a simultaneous pancreas kidney transplant, researchers said… read more.
by Thomas R. Collins – The blood pressure of the kidney transplant recipient at the University of Glasgow kept climbing. But it wasn’t without effort from physicians.
by Thomas R. Collins – The functional status of transplant recipients is a factor that is often overlooked as kidneys are allocated,
by Thomas R. Collins – The BK virus, and damage to the kidney that is caused by it, poses a continuing challenge to kidney transplant specialists.
by Thomas R. Collins – A method for cross-matching organ donors and recipients — using beads and human complement — is producing more reliable results, making for transplantation of hearts… read more.
by Thomas R. Collins – Tracking living kidney donor outcomes in a comprehensive way is fraught with difficulties and complications,
by Mr Nizam Mamode – Transplantation, especially renal transplantation, now seems a fairly straightforward technique. A kidney is removed, usually laparoscopically, then implanted in pretty much the same… read more.
by Christine Clark – Changes in the diagnosis and treatment of cancer form the basis for future developments. There have been many revolutions in medical science over the… read more.
by Christine Clark – The Bayer satellite symposium, ‘The new oral anticoagulants: mechanisms, evidence and day-to-day decisions’, was held at the European Association of Hospital Pharmacists Congress in… read more.
by Bruce Sylvester – Emerging uses of FDA Approved Drugs – Treatment with pazopanib nearly tripled progression-free survival (PFS), compared with placebo, among patients with metastatic soft-tissue sarcoma… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
